ArticleThe Lancet. Oncology2026

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Julia R Dixon-Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.